Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure

HH Chen, MM Redfield, LJ Nordstrom, DP Horton… - Journal of cardiac …, 2004 - Elsevier
BACKGROUND: Brain natriuretic peptide (BNP) is a cardiac hormone with vasodilating,
natriuretic, renin-angiotensin-aldosterone–inhibiting and lusitropic properties. We have …
被引用次数：78 相关文章

[引用][C] Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure

HH Chen, MM Redfield, LJ Nordstrom… - Journal of Cardiac …, 2004 - infona.pl
Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure
× Close The Infona portal uses cookies, ie strings of text saved by a browser on the user's …

Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure

HH Chen, MM Redfield, LJ Nordstrom… - … of cardiac failure, 2004 - pubmed.ncbi.nlm.nih.gov
Background Brain natriuretic peptide (BNP) is a cardiac hormone with vasodilating,
natriuretic, renin-angiotensin-aldosterone-inhibiting and lusitropic properties. We have …

Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure.

HH Chen, MM Redfield, LJ Nordstrom… - Journal of Cardiac …, 2004 - europepmc.org
BACKGROUND: Brain natriuretic peptide (BNP) is a cardiac hormone with vasodilating,
natriuretic, renin-angiotensin-aldosterone-inhibiting and lusitropic properties. We have …

Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure

HH Chen, MM Redfield… - Journal of …, 2004 - mayoclinic.elsevierpure.com
Background Brain natriuretic peptide (BNP) is a cardiac hormone with vasodilating,
natriuretic, renin-angiotensin-aldosterone-inhibiting and lusitropic properties. We have …